Home
About
About
Management
Board of Directors
Scientific Advisory Board
Protein Antibacterials
Protein Antibacterials
Bacteriocins
Lysins
Ectolysin
P128
Pipeline
Bacteriophages
Bacteriophages
Novel
Applications
Services
Services
Collaborative Research
Media
News and Events
Posters and
Presentations
Publications
Contact
Contact
Business Development
and Licensing
Careers
Office Location
News and Events
GangaGen Achieves Initial CARB-X Milestone for Klebicin Program Targeting Pneumonia caused by Multidrug-resistant Klebsiella pneumoniae Bacteria and Secures US$2.1 Million for Lead Optimization
August 11, 2023
Exciting Sports Day at GangaGen
July 28, 2023
GangaGen Celebrates Employee Achievements
June 1, 2023
CARB-X is Funding GangaGen Biotechnologies to Develop a New Drug to Treat Pneumonia Caused by Multidrug-Resistant Klebsiella Pneumoniae Bacteria
October 4, 2020
Back to Top